About
EVIIVE AG develops blood-based diagnostics by profiling extracellular vesicles using single-EV multi-omics technology to discover biomarkers that guide immuno-oncology treatment selection and companion diagnostics.
Explore EVIIVE AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.